Lv12
80 积分 2024-11-05 加入
Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study
3分钟前
已采纳
Deep Learning from Three-dimensional Lithium-ion Battery Multiphysics Model Part I: Data Development
12分钟前
已采纳
MiR-181 Enhances Proliferative and Migratory Potentials of Retinal Endothelial Cells in Diabetic Retinopathy by Targeting KLF6
皖公网安备34019202002308
